Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Oncoimmunology|March 1, 2021
Ectopic CD137 expression by rhabdomyosarcoma provides selection advantages but allows immunotherapeutic targetingKang Yi Lee, Hiu Yi Wong, Qun Zeng, et al.
Experimental and Molecular Pathology|October 4, 2011
Admission levels of soluble CD137 are increased in patients with acute pancreatitis and are associated with subsequent complicationsZhe Shao, Andreas Schäffler, Okka Hamer, et al.
Cancer Research|December 4, 2012
Expression of CD137 on Hodgkin and Reed-Sternberg cells inhibits T-cell activation by eliminating CD137 ligand expressionWeng Tong Ho, Wan Lu Pang, Siew Meng Chong, et al.
Journal of Neuroimmunology|February 20, 2025
Efficacy of rituximab on antibody-positive small fiber neuropathy: A series of 5 casesAmanda C Y Chan, R Shahana, Kewin T H Siah, et al.
European Journal of Immunology|October 20, 2011
Macrophages in human colorectal cancer are pro-inflammatory and prime T cells towards an anti-tumour type-1 inflammatory responseSiew-Min Ong, Yann-Chong Tan, Ottavio Beretta, et al.
Journal of Neuroinflammation|October 2, 2025
Interferon-induced GTP-binding protein MX1 drives hyperexcitability in peripheral nerves: a novel mechanism in small fiber neuropathyAmanda C Y Chan, Hua Huang, Ameen Shah, et al.
Nature Communications|April 17, 2021
DUSP16 promotes cancer chemoresistance through regulation of mitochondria-mediated cell deathHeng Boon Low, Zhen Lim Wong, Bangyuan Wu, et al.
Cancer Immunology, Immunotherapy : CII|March 17, 2022
Epstein-Barr virus-induced ectopic CD137 expression helps nasopharyngeal carcinoma to escape immune surveillance and enables targeting by chimeric antigen receptorsMukul Prasad, Sashigala Ponnalagu, Qun Zeng, et al.
Annals of Neurology|November 11, 2021
Novel Autoantibodies in Idiopathic Small Fiber NeuropathyAmanda C Y Chan, Hiu Yi Wong, Yao Feng Chong, et al.
Cancer Immunology, Immunotherapy : CII|October 18, 2021
Dendritic cell therapy with CD137L-DC-EBV-VAX in locally recurrent or metastatic nasopharyngeal carcinoma is safe and confers clinical benefitEmily Nickles, Bhushan Dharmadhikari, Li Yating, et al.
Pageof 9